In vitro Antifungal Efficacy of Biguanides and Quaternary Ammonium Compounds against Cleanroom Fungal Isolates

References

1. 1.↵
   1. Dupont B.

   An epidemiological review of systemic fungal infections. Journal de Mycologie Medicale 2002 12, 163– 173.

   OpenUrl
2. 2.↵
   1. Pitt J. I.,
   2. Hocking A. D.

   Fungi and Food Spoilage, 2nd ed.; Blackie Academic and Professional: London, 1997.
3. 3.↵
   1. Block S. S.

   1. Larson E. L.,
   2. Morton H. E.

   Alcohols. In Disinfection, Sterilization, and Preservation, 4th ed; Block S. S. Ed.; Lea & Febiger: Philadelphia, PA, 1991; pp 191– 203.
4. 4.↵
   1. Russell A. D.

   Activity of biocides against mycobacteria. J. Appl. Bacteriol. Symp. Suppl. 1996, 81, 87– 101.

   OpenUrl
5. 5.↵
   1. Nagarkar P. P.,
   2. Ravetkar S. D.,
   3. Watve M. G.

   Oligophilic bacteria as tools to monitor aseptic pharmaceutical production units. Appl. Environ. Microbiol. 2001, 67 (3),1371– 1374.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   Chapter 〈1116〉 Microbiological Evaluation of Cleanrooms. In United States Pharmacopoeia/National Formulary, 34th ed.; U.S. Pharmacopeial Convention: Rockville, MD, 2011.
7. 7.↵
   1. Utescher C. L. A.,
   2. Franzolin M. R.,
   3. Trabulsi L. R.,
   4. Gambale V.

   Microbiological monitoring of clean rooms in development of vaccines. Brazilian Journal of Microbiology 2007, 38, 710– 716.

   OpenUrl
8. 8.↵
   1. Bartnett C.,
   2. Polarine J.,
   3. Lopolito P.

   Control strategies for fungal contamination in cleanrooms. Controlled Environments 2007, September.
9. 9.↵
   Chapter 〈1072〉 Disinfectants and Antiseptics. In United States Pharmacopeia 32–National Formulary 23; U.S. Pharmacopoeial Convention, Inc.: Rockville, MD, 2008.
10. 10.↵
    Manufacture of Sterile Medicinal Products. 61. Sanitation. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use–Annex 1, 2008.
11. 11.↵
    1. Patterson T. F.,
    2. Kirkpatrick W. R.,
    3. White M,
    4. Hiemenz J. W.,
    5. Wingard J. R.,
    6. Dupont B.,
    7. Rinaldi M. G.,
    8. Stevens D. A.,
    9. Graybill J. R.

    Invasive aspergillosis—disease spectrum, treatment practices, and outcomes. Medicine 2000, 79, 250– 260.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.
    1. Mellado E.,
    2. Garcia-Effron G.,
    3. Alcazar-Fuoli L.,
    4. Melchers W. J. G.,
    5. Verweij P. E.,
    6. Cuenca-Estrella M.,
    7. Rodríguez-Tudela J. L.

    A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob. Agents Chemother. 2007, 51, 1897– 1904.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Moore C. B.,
    2. Sayers N.,
    3. Mosquera J.,
    4. Slaven J.,
    5. Denning D. W.

    Antifungal drug resistance in Aspergillus. J. Infection 2000, 41, 203– 220.

    OpenUrl
14. 14.↵
    CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard. (2002) CLSI document M38-A, Wayne, Pennsylvania.
15. 15.↵
    1. McDonnell G.,
    2. Russell A. D.

    Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999, 12, 147– 179.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Patrick P.,
    2. Aires J. R.,
    3. Godard C.,
    4. Kohler T.

    Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa. J. Bacteriol. 1997, 179 (22), 7004– 7010.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Hope C. K.,
    2. Wilson M.

    Analysis of the effects of chlorhexidine on oral biofilm vitality and structure sased on viability profiling and an indicator of membrane integrity. Antimicrob. Agents Chemother. 2004, 48 (5),1461– 1468.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Russell A. D.,
    2. Day M. J.

    Antibacterial activity of chlorhexidine. J. Hosp. Infect. 1993, 25, 229– 238.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Hamers A. D.,
    2. Shay K.,
    3. Hahn B. L.,
    4. Sohnle P. G.

    Use of microtiter plate assay to detect the rate of killing of adherent Candida albicans by antifungal agents. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 1996, 81, 44– 49.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.
    1. Giuliana G.,
    2. Pizzo G.,
    3. Milici M. E.,
    4. Musotto G. C.,
    5. Giangreco R.

    In vitro antifungal properties of mouthrinses containing antimicrobial agents. Journal of Periodotonlogy 1997, 68, 729– 733.

    OpenUrl
21. 21.
    1. Ellepola A. N. B.,
    2. Samaranayake L. P.

    Adjunctive use of chlorhexidine in oral candidoses: a review. Oral Diseases 2001, 7, 11– 17.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Ferguson J. W.,
    2. Hatton J. F.,
    3. Gillespie M. J.

    Effectiveness of intracanal irrigants and medications against the yeast Candida albicans. Journal of Endodontics 2002, 28, 68– 71.

    OpenUrlPubMed
23. 23.↵
    1. Tortorano A. M.,
    2. Viviani M. A.,
    3. Biraghi E.,
    4. Rigoni A. L.,
    5. Prigitano A.,
    6. Grillot R.

    In vitro testing of fungicidal activity of biocides against Aspergillus fumigatus. J. Med. Microbiol. 2005, 54, 955– 957.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Day S.,
    2. Lalitha P.,
    3. Haug S.,
    4. Fothergill A. W.,
    5. Cevallos V.,
    6. Vijayakumar R.,
    7. Prajna N. V.,
    8. Acharya N. R.,
    9. McLead S. D.,
    10. Lietman T. M.

    Activity of antibiotics against Fusarium and Aspergillus. Br. J. Ophthalmol. 2009, 93, 116– 119.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Russell A. D.,
    2. Furr J. R.

    Biocides: mechanisms of antifungal action and fungal resistance. Sci. Prog. 1996, 79, 27– 28.

    OpenUrlPubMed
26. 26.↵
    1. Russell A. D.,
    2. Gould G. W.

    Resistance of enterobacteriaceae to Preservatives and disinfectants. J. Appl. Bacteriol. Symp. Suppl. 1988, 65, 167S– 195S.

    OpenUrl
27. 27.
    1. Russell A. D.,
    2. Hugo W. B.,
    3. Ayliffe G. A. J.

    1. Hugo W. B.,
    2. Russell A. D.

    Types of antimicrobial agents. In Principles and Practice of Disinfection, Preservation and Sterilization, 3rd ed.; Russell A. D., Hugo W. B., Ayliffe G. A. J. Eds.; Blackwell Science: Oxford, England, 1999.
28. 28.↵
    1. McDonnell G.,
    2. Russell A. D.

    Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 1999, 12 (1),147– 79.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Jose E.

    ; Martinez. The rotation of disinfectants principle: true or false? Pharm. Technol. 2009, 33 (2),58– 71.

    OpenUrl